Carotid atherosclerosis progression and ACAT inhibition.
Parini
Paolo
P
Eriksson
Mats
M
Rudel
Lawrence L
LL
D000818:Animals; D002340:Carotid Artery Diseases / Q000517:prevention & control*; D004791:Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy; D006951:Hyperlipoproteinemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D007210:Indoleacetic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D002785:Sterol O-Acyltransferase / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D000097587:Sterol O-Acyltransferase 2
D004791:Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D007210:Indoleacetic Acids; D002785:Sterol O-Acyltransferase; D000097587:Sterol O-Acyltransferase 2; C509302:pactimibe; C493492:sterol O-acyltransferase 1